Pharmaceutical Manufacturing Handbook: Production and

866 VAGINAL DRUG DELIVERY
nanospheres induces a signifi cant HIV1 - specifi c vaginal antibody response in mice ,
J. Med. Virol. , 69 , 163 – 172 .
161. Bonucci , E. , Ballanti , P. , Ramires , P. A. , Richardson , J. L. , and Benedetti , L. M. ( 1995 ),
Prevention of ovariectomy osteopenia in rats after vaginal administration of Hyaff 11
microspheres containing salmon calcitonin , Calcif. Tissue Int. , 56 , 274 – 279 .
162. Bilensoy , E. , Rouf , M. A. , Vural , I. , Sen , M. , and Hincal , A. A. ( 2006 ), Mucoadhesive,
thermosensitive, prolonged - release vaginal gel for clotrimazole:beta - cyclodextrin
complex , AAPS PharmSciTech , 7 , E38 .
163. Francois , M. , Snoeckx , E. , Putteman , P. , Wouters , F. , De Proost , E. , Delaet , U. , Peeters ,
J. , and Brewster , M. E. ( 2003 ), A mucoadhesive, cyclodextrin - based vaginal cream formulation
of itraconazole , AAPS PharmSci , 5 , E5 .
164. Ahmed , M. O. , El - Gibaly , I. , and Ahmed , S. M. ( 1998 ), Effect of cyclodextrins on the
physicochemical properties and antimycotic activity of clotrimazole , Int. J. Pharm. , 171 ,
111 – 121 .
165. Shihata , A. ( 2004 ), New FDA - approved woman - controlled, latex - free barrier contraceptive
device “ Fem Cap , ” Int. Congr. Ser. , 1271 , 303 – 306 .
166. Lee , C. H. , Bagdon , R. E. , Bhatt , P. P. , and Chien , Y. W. ( 1997 ), Development of silicone -
based barrier devices for controlled delivery of spermicidal agents , J. Controlled Release ,
44 , 43 – 53 .
167. McCarron , P. A. , Donnelly , R. F. , Gilmore , B. F. , Woolfson , A. D. , McClelland , R. ,
Zawislak , A. , and Price , J. H. ( 2004 ), Phototoxicity of 5 - aminolevulinic acid in the HeLa
cell line as an indicative measure of photodynamic effect after topical administration to
gynecological lesions of intraepithelial form , Pharm. Res. , 21 , 1871 – 1879 .
168. Woolfson , A. D. , McCafferty , D. F. , McCarron , P. A. , and Price , J. H. ( 1995 ), A bioadhesive
patch cervical drug delivery system for the administration of 5 - fl uorouracil to cervical
tissue , J. Controlled Release , 35 , 49 – 58 .
169. Mazouni , C. , Provensal , M. , Menard , J. P. , Heckenroth , H. , Guidicelli , B. , Gamerre , M. ,
and Bretelle , F. ( 2006 ), Utilisation du dispositif vaginal Propess dans le d é clenchement
du travail: Effi cacit é et innocuit é , Gynecol. Obstet. Fertil. , 34 , 489 – 492 .
170. Vollebregt , A. , van ’ t Hof , D. B. , and Exalto , N. ( 2002 ), Prepidil compared to Propess for
cervical ripening , Eur. J. Obstet. Gynecol. Reprod. Biol. , 104 , 116 – 119 .
171. Tedajo , G. M. , Bouttier , S. , Grossiord , J. L. , Marty , J. P. , Seiller , M. , and Fourniat , J. ( 2002 ),
In vitro microbicidal activity of W/O/W multiple emulsion for vaginal administration ,
Int. J. Antimicrob. Agents , 20 , 50 – 56 .
172. Kaushal , G. , Trombetta , L. , Ochs , R. S. , and Shao , J. ( 2006 ), Delivery of TEM beta -
lactamase by gene - transformed Lactococcus lactis subsp. lactis through cervical cell
monolayer , Int. J. Pharm. , 313 , 29 – 35 .
173. Yao , X. Y. , Yuan , M. M. , and Li , D. J. ( 2006 ), Mucosal inoculation of Lactobacillus
expressing hCGbeta induces an anti - hCGbeta antibody response in mice of different
strains , Methods , 38 , 124 – 132 .
174. Vail , J. G. , Cohen , J. A. , and Kelly , K. L. ( 2004 ), Improving topical microbicide applicators
for use in resource - poor settings , Am. J. Public Health , 94 , 1089 – 1092 .
175. Costa , P. , and Sousa Lobo , J. M. ( 2001 ), Modeling and comparison of dissolution profi les ,
Eur. J. Pharm. Sci. , 13 , 123 – 133 .
176. Siewert , M. , Dressman , J. , Brown , C. K. , and Shah , V. P. ( 2003 ), FIP/AAPS guidelines to
dissolution/in vitro release testing of novel/special dosage forms , AAPS PharmSciTech ,
4 , E7 .
177. Karasulu , H. Y. , Hilmioglu , S. , Metin , D. Y. , and Guneri , T. ( 2004 ), Effi cacy of a new
ketoconazole bioadhesive vaginal tablet on Candida albicans , Farmaco , 59 , 163 – 167 .